Antibe Therapeutics Inc. Announces Proposed Offering of Units
(WorldNews Canada)

Antibe Therapeutics Inc. Announces Proposed Offering of Units Antibe Therapeutics Inc. (`Antibe` or the `Company`) (TSXV: ATE) (OTCQX: ATBPF) a diversified biotechnology company announced today that it has filed a preliminary short form prospectus in connection with a proposed marketed offering of units of the Company (the `Units`) for minimum gross proceeds of $3,000,000 and maximum gross proceeds of $5,000,000 (the `Offering`). Each Unit will be comprised of one common share of the Company and one half of one common share purchase warrant (each full warrant, a `Warrant`). The Offering will be undertaken on a `best efforts` agency basis in the provinces of Ontario,...